What are the optimal treatment modalities according to age group in gastric cancer patients?

被引:0
|
作者
Zirtiloglu, Alisan [1 ]
Cil, Ibrahim [1 ]
Velibeyoglu, Fatih Mehmet [2 ]
Tural, Deniz [1 ]
机构
[1] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Med Oncol, Istanbul, Turkey
[2] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey
来源
JOURNAL OF BUON | 2017年 / 22卷 / 02期
关键词
age group; gastric cancer; geriatric patients; optimal management; outcome; treatment modality; LYMPH-NODE DISSECTION; MULTICENTER PHASE-II; CLINICOPATHOLOGICAL CHARACTERISTICS; EXTENDED LYMPHADENECTOMY; ELDERLY-PATIENTS; D2; GASTRECTOMY; SURVIVAL; PROGNOSIS; SURGERY; CHEMOTHERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer in older people has become an increasingly common problem due to the prolonged life expectancy of the general population. Cancer treatment is challenging but it can be more difficult in geriatric population. Aging is associated with progressive reduction of the body's functional capacity and increased prevalence of chronic diseases. As a result, cancer treatment could cause higher prevalence of serious side effects. In the literature there are only sparse studies about treatment modalities in geriatric gastric cancer patients, therefore our aim was to review the literature concerning this topic and reach a sound conclusion.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 50 条
  • [21] Differences in the prognosis of early gastric cancer according to sex and age
    Suh, Do Dam
    Oh, Seong Tae
    Yook, Jeong Hwan
    Kim, Byung-Sik
    Kim, Beom Su
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (02) : 219 - 229
  • [22] Prognosis factors of advanced gastric cancer according to sex and age
    Abdulaziz Alshehri
    Hussain Alanezi
    Beom Su Kim
    World Journal of Clinical Cases, 2020, (09) : 1608 - 1619
  • [23] Adjuvant Therapy in Gastric Cancer: What Is The Optimal Approach?
    Takashi Taketa
    Kazuki Sudo
    Roopma Wadhawa
    Mariela M. Blum
    Jaffer A. Ajani
    Current Oncology Reports, 2013, 15 : 146 - 151
  • [24] Adjuvant Therapy in Gastric Cancer: What Is The Optimal Approach?
    Taketa, Takashi
    Sudo, Kazuki
    Wadhawa, Roopma
    Blum, Mariela M.
    Ajani, Jaffer A.
    CURRENT ONCOLOGY REPORTS, 2013, 15 (02) : 146 - 151
  • [25] What is the optimal starting time of adjuvant treatment in breast cancer patients?
    Durnali, Ayse G.
    Alkis, Necati
    Utkan, Gungor
    Celenkoglu, Gokhan
    Arslan, Ulku Y.
    Muallaoglu, Sadik
    Kocer, Murat
    Tokluoglu, Saadet
    ANNALS OF ONCOLOGY, 2006, 17 : 108 - 109
  • [26] What is the most satisfactory treatment for skin tightening according to age?
    Suh, Dong Hye
    Ahn, Hye Jin
    Lee, Sang Jun
    Jeong, Ki Heon
    Song, Kye Yong
    Shin, Min Kyung
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB313 - AB313
  • [27] What is the optimal length of treatment of group A streptococcal tonsillitis?
    Flückiger, U
    HNO, 2001, 49 (04) : 253 - 255
  • [28] Current adjuvant treatment modalities for gastric cancer: From history to the future
    Kilic, Leyla
    Ordu, Cetin
    Yildiz, Ibrahim
    Sen, Fatma
    Keskin, Serkan
    Ciftci, Rumeysa
    Pilanci, Kezban Nur
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (05) : 439 - 449
  • [29] The impact of neoadjuvant and/or adjuvant treatment modalities in resectable gastric cancer (rGC).
    Ng, Camille
    Kim, Sungjin
    Guan, Michelle
    Hendifar, Andrew Eugene
    Kim, Haesoo
    Liu, Jar-Yee
    Mehta, Sejal
    Placencio-Hickok, Veronica
    Gangi, Alexandra
    Klempner, Samuel J.
    Burch, Miguel
    Chao, Joseph
    Cho, May Thet
    Kamrava, Mitchell
    Atkins, Katelyn Mae
    Gong, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Current adjuvant treatment modalities for gastric cancer:From history to the future
    Leyla Kilic
    Cetin Ordu
    Ibrahim Yildiz
    Fatma Sen
    Serkan Keskin
    Rumeysa Ciftci
    Kezban Nur Pilanci
    World Journal of Gastrointestinal Oncology, 2016, 8 (05) : 439 - 449